Effect of medroxyprogesterone on inspiratory flow shapes during sleep in postmenopausal women

Respiratory Physiology and Neurobiology

Volumn 134, Issue 2, 2003, Pages 131-143

  Saaresranta, Tarja ^a,d   Aittokallio, Tero ^b   Polo Kantola, Päivi ^a,d   Helenius, Hans ^c   Polo, Olli ^a,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b TURKU CENTRE FOR COMPUTER SCIENCE   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Control of breathing, respiratory drive; Hormones, progesterone; Mammals, humans; Pattern of breathing, postmenopausal women; Sleep, inspiratory flow shape, progesterone

Indexed keywords

MEDROXYPROGESTERONE ACETATE; RESPIRATORY STIMULANT AGENT;

ARTICLE; BIOTRANSFORMATION; BREATHING; CARBON DIOXIDE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; POSTMENOPAUSE; PRIORITY JOURNAL; SLEEP; UPPER RESPIRATORY TRACT OBSTRUCTION;

FEMALE; HUMANS; INSPIRATORY CAPACITY; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POLYSOMNOGRAPHY; POSTMENOPAUSE; PROGESTERONE CONGENERS; SLEEP STAGES; SPIROMETRY;

EID: 0345269989     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9048(02)00208-2     Document Type: Article

References (36)

1. Aittokallio T., Nevalainen O., Pursiheimo U., Saaresranta T., Polo O. Classification of nasal inspiratory flow shapes by attributed finite automata. Comput. Biomed. Res. 32:1999;34-55.
2. Aittokallio T., Saaresranta T., Polo-Kantola P., Nevalainen O., Polo O. Analysis of inspiratory flow shapes in patients with partial upper-airway obstruction during sleep. Chest. 119:2001;37-44.
3. EEG arousals: scoring rules and examples. Sleep. 15:1992;175-184.
4. Ayappa I., Norman R.G., Krieger A.C., Rosen A., O'malley R.L., Rapoport D.M. Non-invasive detection of respiratory effort-related arousals (RERAs) by a nasal cannula/pressure transducer system. Sleep. 23:2000;763-771.
5. Berthon-Jones M. Feasibility of a self-setting CPAP machine. Sleep. 16:1993;S120-S123.
6. Block A.J., Wynne J.W., Boysen P.G., Lindsey S., Martin C., Cantor B. Menopause, medroxyprogesterone and breathing during sleep. Am. J. Med. 70:1981;506-510.
7. Cistulli P.A., Barnes D.J., Grunstein R.R., Sullivan C.E. Effect of short term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax. 49:1994;699-702.
8. Clark S.A., Wilson C.R., Satoh M., Pegelow D., Dempsey J.A. Assessment of inspiratory flow limitation invasively and noninvasively durind sleep. Am. J. Respir. Crit. Care Med. 158:1998;713-722.
9. Condos R., Norman R.G., Krishnasamy I., Peduzzi N., Goldring R.M., Rapoport D.M. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 150:1994;475-480.
10. Farre R., Rigau J., Montserrat J.M., Ballester E., Navajas D. Relevance of linearizing nasal prongs for assessing hypopneas and flow limitation during sleep. Am. J. Respir. Crit. Care Med. 163:2001;494-497.
11. Heitman S.J., Atkar R.S., Hajduk E.A., Wanner R.A., Flemons W.W. Validation of nasal pressure for the identification of apneas/hypopneas during sleep. Am. J. Respir. Crit. Care Med. 166:2002;386-391.
12. Hensley M.J., Saunders N.A., Strohl K.P. Medroxyprogesterone treatment of obstructive sleep apnea. Sleep. 3:1980;441-446.
13. Hernández L., Ballester E., Farre R., Badia J.R., Lobelo R., Navajas D., Montserrat J.M. Performance of nasal prongs in sleep studies: spectrum of flow-related events. Chest. 119:2001;442-450.
14. Hosselet J.-J., Norman R.G., Ayappa I., Rapoport D.M. Detection of flow limitation with a nasal cannula/pressure transducer system. Am. J. Respir. Crit. Care Med. 157:1998;1461-1467.
15. Hudgel D.W., Thanakitcharu S. Pharmacologic treatment of sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 158:1998;691-699.
16. Johansson E.D.B., Johansen P.B., Rasmussen S.N. Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation. Acta Pharmacol. Toxicol. 58:1986;311-317.
17. Keefe D.L., Watson R., Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause. 6:1999;196-200.
18. Montserrat J.M., Ballester E., Olivi H., Reolid A., Lloberes P., Morello A., Rodriguez-Roisin R. Time-cource of stepwise CPAP titration. Behavior of respiratory and neurological variables. Am. J. Respir. Crit. Care Med. 152:1995;1854-1859.
19. Norman R.G., Ahmed M.M., Walsleben J.A., Rapoport D.M. Detection of respiratory events during NPSG: nasal cannula/pressure sensor versus thermistor. Sleep. 20:1997;1175-1184.
20. O'Connor C., Thornley K.S., Hanly P.J. Gender differences in the polysomnographic features of obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 161:2000;1465-1472.
21. Pickett C.K., Regensteiner J.G., Woodard W.D., Hagerman D.D., Weil J.V., Moore L.G. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J. Appl. Physiol. 66:1989;1656-1661.
22. Polo O. Partial upper airway obstruction during sleep. Studies with the static-charge-sensitive bed (SCSB). Acta Physiol. Scand. 145:1992;1-118.
23. Polo-Kantola, P., 1999. Sleep, menopause and estrogen replacement therapy. Dissertation, Ann. Univ. Turkuensis D367, 176 p.
24. Polo-Kantola P., Erkkola R., Irjala K., Pullinen S., Virtanen I., Polo O. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil. Steril. 71:1999;873-880.
25. Popovic R.M., White D.P. Upper airway muscle activity in normal women: influence of hormonal status. J. Appl. Physiol. 84:1998;1055-1062.
26. Rechtschaffen A., Kales A.A. A Manual of Standardized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subjects. 1968;National Institute of Health, Washington DC.
27. Rees K., Wraith P.K., Berthon-Jones M., Douglas N.J. Detection of apnoeas, hypopnoeas and arousals by the AutoSet in the sleep apnoea/hypopnoea syndrome. Eur. Respir. J. 12:1998;764-769.
28. Saaresranta T., Polo-Kantola P., Irjala K., Helenius H., Polo O. Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate. Chest. 115:1999;1581-1587.
29. Saaresranta T., Polo-Kantola P., Rauhala E., Polo O. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep. Eur. Respir. J. 18:2001;989-995.
30. Schoene R.B., Pierson D.J., Lakshminarayan S., Shrader D.L., Butler J. Effect of medroxyprogesterone acetate on respiratory drives and occlusion pressure. Bull. Eur. Physiopathol. Resp. 16:1980;645-653.
31. Sériès F., Desmeules C.M., LaForge J. Effects of respiratory drive on upper airways in sleep apnea patients and normal subjects. J. Appl. Physiol. 67:1989;973-979.
32. Skatrud J.B., Dempsey J.A., Kaiser D.G. Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. J. Appl. Physiol. 44:1978;939-944.
33. Teschler H., Berthon-Jones M., Thompson A.B., Henkel A., Henry J., Konietzko N. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 154:1996;734-740.
34. Thurnheer R., Xie X., Bloch K.E. Accuracy of nasal cannula pressure recordings for assessment of ventilation during sleep. Am. J. Respir. Crit. Care Med. 164:2001;1914-1919.
35. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328:1993;1230-1235.
36. Zwillich C.W., Natalino M.R., Sutton F.D., Weil J.V. Effects of progesterone on chemosensitivity in normal men. J. Lab. Clin. Med. 92:1978;262-269.